Bruce S. Ross
Isis Pharmaceuticals
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bruce S. Ross.
Nucleosides, Nucleotides & Nucleic Acids | 1997
Bruce S. Ross; Robert H. Springer; Zeb Tortorici; Stuart Dimock
Abstract A highly efficient, two-step method to make 2′-O-methyluridine is described using only inexpensive reagents and no chromatography. The method is applicable for some other alkyls as well as some other pyrimidine derivatives.
Nucleosides, Nucleotides & Nucleic Acids | 2005
Bruce S. Ross; Quanlai Song; Mingming Han
We describe an improved process to produce 2′-O-(2-methoxyethyl)-pyrimidines. Starting with commercially available O-2,2′-anhydro-5-methyluridine and tris-(2-methoxyethyl)borate, we modified the ring-opening reaction conditions and changed to a continuous extraction purification method to give 2′-O-(2-methoxyethyl)-5-methyluridine. The dimethoxytritylation 5′/3′ ratios and yield were improved by the use of 2,6-lutidine as the base. Conditions to convert to the 5-methylcytidine analog and its isolation by crystallization were optimized. Final benzoylation was improved by developing a method to selectively hydrolyze benzoyl ester impurities.
Nucleosides, Nucleotides & Nucleic Acids | 1997
Bruce S. Ross; Guillermo Vasquez; Sheri Manalili; Elena A. Lesnik; Richard H. Griffey
Abstract A short multigram synthesis of 2′-O-methylpseudouridine and its phosphoramidite derivative is described which avoids the use of protecting groups on the nitrogens. A binding study of oligonucleotides containing this modification suggest an increased binding affinity to RNA when compared to oligonucleotides incorporating 2′-O-methyluridine.
Nucleosides, Nucleotides & Nucleic Acids | 1997
Muthiah Manoharan; Gopal B. Inamati; Kathleen L. Tivel; Boyd Conklin; Bruce S. Ross; P. Dan Cook
Abstract Recently our laboratory introduced1 chemistries to synthesize 2′- and 3′- cholesteroluridine conjugates which were incorporated into several antisense oligonucleotides. We have now extended this chemistry to other nucleosides (adenosine and cytosine) and synthesized antisense oligonucleotide conjugates for several disease targets. Synthesis of these cholesterol nucleosides was carried out hy condensing choleskrol chloroformate with 2′-O-alkylamine or 3′-O-alkylamine of the appropriate nucleoside. The 2′-O-alkylamines were deiived from direct alkylation procedure.
Tetrahedron Letters | 1994
Yogesh S. Sanghvi; Bruce S. Ross; Ramesh Bharadwaj; Jean-Jacques Vasseur
Abstract A large-scale, facile and stereoselective synthesis of 1-[5- O -( tert -butyldiphenylsilyl)-2,3-dideoxy-3-α- C -formyl-β-D-erythro-pentofuranosyl] -adenine ( 7b ) and - N 2 -isobutyrylguanine ( 7c ) using an intermolecular radical CC bond formation reaction is reported. The utility of these nucleosides ( 7b and 7c ) as building blocks for antisense oligonucleosides is discussed.
Nucleosides, Nucleotides & Nucleic Acids | 2006
Bruce S. Ross; Mingming Han; Vasulinga T. Ravikumar
An efficient process to synthesize 5′-O-dimethoxytrityl-N4-benzoyl-5-methyl-2 ′-deoxycytidine in high yield and quality is described. Final benzoylation was improved by developing a method to selectively hydrolyze benzoyl ester impurities. This inexpensive approach was scaled up to multi-kilogram quantities for routine use in oligonucleotide therapeutics.
Nucleosides, Nucleotides & Nucleic Acids | 1997
Bruce S. Ross; Robert H. Springer; Kelly G. Sprankle; Guillermo Vasquez
Abstract An efficient conversion from commercially available 2, 6-diaminopurine-2′, 3′, 5′-tri-O-benzyl arabinoside to arabinosylguanine and its further transformation to 2′-deoxy-2′-fluoro-guanosine is outlined. This process has been used to produce more than one hundred grams of final product.
Nucleosides, Nucleotides & Nucleic Acids | 2008
Shabbir Ali S. Taj; S. Narayanan; S. Suman Meenakshi; Yogesh S. Sanghvi; Bruce S. Ross; Vasulinga T. Ravikumar
An optimized process to synthesize DMT protected 2 ′-O-methoxyethylguanosine is described. A key step involves the enzymatic deamination of a mixture of alkylated products to selectively afford the desired material without resorting to chromatography for purification. This approach was scaled up to kilogram quantities for use in oligonucleotide therapeutics.
Nucleosides, Nucleotides & Nucleic Acids | 2008
Bruce S. Ross; Robert H. Springer; Vasulinga T. Ravikumar
An efficient process to synthesize 2,6-diaminopurine riboside in high yield and quality is described. This inexpensive approach was scaled up to multi-hundred kilogram quantities for use in oligonucleotide therapeutics.
Nucleosides, Nucleotides & Nucleic Acids | 1999
Muthiah Manoharan; Thazha P. Prakash; Isabelle Barber-Peoc'h; Balkrishen Bhat; Guillermo Vasquez; Bruce S. Ross; P. Dan Cook
Abstract A new protecting group, 2-cyanoethyloxycarbonyl, or CEOC, has been developed for amino groups and utilized in synthesizing modified oligonucleotides. (CEOC)-oxy-succinimide reagent has been synthesized to introduce this protecting group. The protecting group is removed by standard oligonucleotide deprotection protocols. Using this approach, oligonucleotides have been synthesized with various types of alkylamine substituents.